Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently ...

Detailed price information for Windtree Therapeutics Inc (WINT-Q) from The Globe and Mail including charting and trades.

Our recently implemented re-structuring and the re-prioritization of our clinical portfolio meaningfully extends our cash runway into late ...

The stripped-back Repare will be focused on its phase 1 clinical assets, namely the PLK4 inhibitor RP-1664 and the Polθ ATPase inhibitor RP-3467. RP-1664 is currently being evaluated as a ...

为解决 F? -ATPase 催化机制的疑问，研究人员开展 F? -ATPase 催化停顿振荡研究。结果发现催化停顿分三个阶段振荡，这完善了其旋转机制。推荐科研读者阅读，助您深入了解细胞能量产生的微观机制。 在微观的细胞世界里，有一个神奇的 “小马达”，它就是 F?

Major Finding: Digoxin treatment reduces circulating tumor cell cluster size in patients with metastatic breast cancer. Concept: Genes involved in cell–cell adhesion and cell cycle pathways are ...

These results indicated that A011 could inhibit the transport function of ABCB1 and ABCG2 transporters. A011 significantly decreased the ATPase activity of the ABCB1 transporter To further investigate ...